[go: up one dir, main page]

MX2018000844A - Composiciones ingeribles por abejas, procedimientos para el uso de las mismas para producir miel y miel producida de esta manera. - Google Patents

Composiciones ingeribles por abejas, procedimientos para el uso de las mismas para producir miel y miel producida de esta manera.

Info

Publication number
MX2018000844A
MX2018000844A MX2018000844A MX2018000844A MX2018000844A MX 2018000844 A MX2018000844 A MX 2018000844A MX 2018000844 A MX2018000844 A MX 2018000844A MX 2018000844 A MX2018000844 A MX 2018000844A MX 2018000844 A MX2018000844 A MX 2018000844A
Authority
MX
Mexico
Prior art keywords
honey
methods
bee
same
producing
Prior art date
Application number
MX2018000844A
Other languages
English (en)
Inventor
Dov Avidov Amit
BEN SIMON Ilan
Original Assignee
Phytopharma Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phytopharma Int Ltd filed Critical Phytopharma Int Ltd
Publication of MX2018000844A publication Critical patent/MX2018000844A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/90—Feeding-stuffs specially adapted for particular animals for insects, e.g. bees or silkworms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
    • A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
    • A23L21/25—Honey; Honey substitutes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Insects & Arthropods (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)

Abstract

Se proporciona una composición ingerible por abejas que comprende una base alimenticia de abejas y THC y/o CBD. Tambión se proporcionan procedimientos para producir miel, miel obtenible por estos procedimientos y usos de los mismos.
MX2018000844A 2015-07-22 2016-07-21 Composiciones ingeribles por abejas, procedimientos para el uso de las mismas para producir miel y miel producida de esta manera. MX2018000844A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562195311P 2015-07-22 2015-07-22
PCT/IL2016/050801 WO2017013661A1 (en) 2015-07-22 2016-07-21 Bee-ingestible compositions, methods of using same for producing honey and honey produced thereby

Publications (1)

Publication Number Publication Date
MX2018000844A true MX2018000844A (es) 2018-07-06

Family

ID=56738142

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018000844A MX2018000844A (es) 2015-07-22 2016-07-21 Composiciones ingeribles por abejas, procedimientos para el uso de las mismas para producir miel y miel producida de esta manera.

Country Status (18)

Country Link
US (3) US10278996B2 (es)
EP (1) EP3324754B1 (es)
JP (1) JP6976242B2 (es)
KR (1) KR102460440B1 (es)
CN (1) CN107846936B (es)
AU (1) AU2016295728B2 (es)
BR (1) BR112018001310A2 (es)
CA (1) CA2993023C (es)
CL (1) CL2018000162A1 (es)
CO (1) CO2018001115A2 (es)
EC (1) ECSP18012359A (es)
ES (1) ES2931903T3 (es)
IL (2) IL257078B (es)
MX (1) MX2018000844A (es)
PE (1) PE20181011A1 (es)
PT (1) PT3324754T (es)
WO (1) WO2017013661A1 (es)
ZA (1) ZA201800595B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013164824A1 (en) 2012-05-03 2013-11-07 Magdent Ltd. Bone enhancement device and method
US10960035B2 (en) 2015-04-01 2021-03-30 The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Voleaui Center) Erodium crassifolium L'Her plant extracts and uses thereof
PT3324754T (pt) 2015-07-22 2022-11-30 Phytopharma Int Ltd Composições ingeríveis por abelhas, métodos de utilização das mesmas para produzir mel e mel produzido desse modo
CA3003094A1 (en) * 2015-10-31 2017-05-04 Aharon M. Eyal Honey-cannabinoid therapeutic composition
CA3007393A1 (en) * 2015-12-05 2017-06-08 Canabuzz-Med Veterinary composition and methods for production and use
EP3445179A4 (en) * 2016-04-19 2020-07-22 Canna-B Cure Ltd ENZYMATICALLY TREATED THERAPEUTIC COMPOSITION ENRICHED IN CANNABIS
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
EP3592346A4 (en) 2017-03-05 2020-12-30 The State of Isreal, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
EP3384785A1 (de) * 2017-04-04 2018-10-10 Marquie-Amadeus Gerster Verfahren zur herstellung eines honig oder propolis enthaltenden lebensmittels, lebensmittel und bienenstock
EP3678658A4 (en) * 2017-09-08 2021-05-05 Scicann Therapeutics Inc. COMPOSITIONS WITH A CANNABINOID AND SPILANTHOL
CA3089994A1 (en) 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
JP2021521277A (ja) * 2018-04-09 2021-08-26 エレヴェット・サイエンシズ 動物における疼痛の処置のためのアサ抽出物
SI25373A (sl) * 2018-05-08 2018-08-31 Danijela Marković Naravna orodisperzibilna tableta
US11040932B2 (en) 2018-10-10 2021-06-22 Treehouse Biotech, Inc. Synthesis of cannabigerol
CN109627148B (zh) * 2018-11-28 2021-09-03 中国农业科学院麻类研究所 一种大麻二酚的制备方法、制得的大麻二酚及其用途
EP3698643A1 (en) 2019-02-04 2020-08-26 Pileckas, Juozas The method of health maintaining and treating of the honey bee using herbal additives
LT6672B (lt) 2019-02-04 2019-10-25 Juozas Pileckas Medunešių bičių sveikatos palaikymo ir gydymo būdas, naudojant vaistinių augalų priedus
LT6671B (lt) 2019-02-04 2019-10-25 Juozas Pileckas Medaus su pakeista sudėtimi gamybos būdas, naudojant vaistinių augalų priedus
KR102149215B1 (ko) * 2019-12-12 2020-08-31 주식회사 바이오포스 수밀력 향상을 위한 꿀벌 사양액용 조성물 및 그의 제조방법
US12016829B2 (en) 2019-10-11 2024-06-25 Pike Therapeutics Inc. Pharmaceutical composition and method for treating seizure disorders
MX2022004257A (es) 2019-10-11 2022-05-26 Pike Therapeutics Inc Composicion farmaceutica y metodo para tratamiento de los trastornos convulsionales.
US12268699B2 (en) 2019-10-14 2025-04-08 Pike Therapeutics Inc. Transdermal delivery of tetrahydrocannabinol
US12121617B2 (en) 2019-10-14 2024-10-22 Pike Therapeutics Inc. Transdermal delivery of cannabidiol
MX2022004258A (es) 2019-10-14 2022-05-26 Pike Therapeutics Inc Entrega transdermica de cannabidiol.
US20210177914A1 (en) * 2019-12-11 2021-06-17 Cannabis Global, Inc. Cannabinoid enriched composition and method of using
IT202000008983A1 (it) 2020-04-24 2021-10-24 Paride Caviggioli Metodo di produzione di prodotti delle api ad alto valore aggiunto
EP4251182A4 (en) * 2020-11-30 2024-10-09 MW Pharma IP Limited STABLE COMPOSITION WITH A HONEY AND A CANNABINOID
KR102278512B1 (ko) * 2021-01-19 2021-07-20 정진욱 광화학 반응시켜 카나비디올 및 풀빅산을 함유하며, 상기 카나비디올 및 풀빅산 성분이 식용 곤충, 파충류, 연체류, 및 가축류로의 천이 가능한 사료 조성물 및 이의 제조방법
WO2023137500A2 (en) * 2022-01-14 2023-07-20 Companion Sciences, Llc Cannabidiol and beta-caryophyllene in combination with condensed tannins and c-ring isomerized condensed tannins (phlobatannins) compositions to treat gynecological diseases and disorders
KR102783391B1 (ko) * 2022-04-27 2025-03-17 강신규 훈련된 꿀벌을 이용한 천연대마 꿀 생산 방법

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB156041A (en) * 1920-05-05 1921-01-06 William Lilley A composition of matter for addition to bee foods
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
JPS61265056A (ja) * 1985-05-20 1986-11-22 Atsuo Inoue 訪花蜂用の即席飼料
KR920010325B1 (ko) * 1988-09-08 1992-11-27 천일제약 주식회사 약용꿀의 제조방법
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
CA2056469C (en) * 1990-11-30 1997-03-25 Hiroaki Oonishi Plastic optical fibers
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
US5612074A (en) * 1995-12-21 1997-03-18 Leach; Robin L. Nutrient fortified food bar
US5711953A (en) 1996-08-26 1998-01-27 Bassett; John M. Insect repellant
JPH1198962A (ja) * 1997-09-25 1999-04-13 Katakura Industries Co Ltd 蜂用飼料
JPH11169098A (ja) * 1997-12-15 1999-06-29 Nippon Haigou Shiryo Kk 養蜂用飼料
JP2000333619A (ja) * 1999-05-28 2000-12-05 Nobuyuki Izena 抗菌効果物質の製造方法並びに抗菌効果物質を用いた養蜂方法
IL136839A (en) 2000-06-16 2006-12-10 Yissum Res Dev Co Pharmaceutical compositions comprising cannabidiol derivatives, and processes for the preparation of same
US8449908B2 (en) 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
GB0103638D0 (en) * 2001-02-14 2001-03-28 Gw Pharmaceuticals Ltd Pharmaceutical formulations
CH695661A5 (de) * 2001-03-06 2006-07-31 Forsch Hiscia Ver Fuer Krebsfo Pharmazeutische Zusammensetzung.
KR20030047388A (ko) * 2001-12-10 2003-06-18 김주인 꿀벌용 액당 사료제조방법
IL148244A0 (en) 2002-02-19 2002-09-12 Yissum Res Dev Co Anti-nausea and anti-vomiting activity of cannabidiol compounds
GB0425248D0 (en) * 2004-11-16 2004-12-15 Gw Pharma Ltd New use for cannabinoid
WO2006080019A1 (en) 2005-01-31 2006-08-03 Tzuf Globus Ltd. Bee-food, honey made by bees fed with it, and uses of such honey
JP2006350211A (ja) 2005-06-20 2006-12-28 Toshiba Matsushita Display Technology Co Ltd 液晶表示装置
JP2008208036A (ja) * 2007-02-23 2008-09-11 Osamu Fukuda ステビア含有養蜂用給餌・防菌液および養蜂給餌・防菌方法、養蜂用防菌剤
GB2448535A (en) * 2007-04-19 2008-10-22 Gw Pharma Ltd New use for cannabinoid-containing plant extracts
GB2450753B (en) * 2007-07-06 2012-07-18 Gw Pharma Ltd New Pharmaceutical formulation
US8642103B2 (en) 2008-01-14 2014-02-04 Prakash Kejriwal Process for preparing chewable honey without loss of its nutritional values and honey chew bar obtained through such process
GB2459637B (en) * 2008-01-21 2012-06-06 Gw Pharma Ltd New use for cannabinoids
CN101467598B (zh) * 2008-04-03 2011-04-20 霍耀锋 用蜜蜂采集的天然中药蜂蜜及其制备方法
GB2471987B (en) * 2008-06-04 2012-02-22 Gw Pharma Ltd Anti-tumoural effects of cannabinoid combinations
CN101869235B (zh) 2009-04-27 2012-11-07 北京百花蜂产品科技发展有限公司 一种蜂蜜膏的配方及制备方法
US8962584B2 (en) 2009-10-14 2015-02-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Compositions for controlling Varroa mites in bees
KR101314099B1 (ko) * 2010-10-19 2013-10-04 일진에프앤피 주식회사 효소를 이용한 꿀벌용 발효화분 떡사료 및 이의 제조방법
US8445034B1 (en) 2010-11-02 2013-05-21 Albert L Coles, Jr. Systems and methods for producing organic cannabis tincture
US8642645B2 (en) * 2011-05-20 2014-02-04 Brooks Kelly Research, LLC. Pharmaceutical composition comprising Cannabinoids
US8808734B2 (en) 2011-07-11 2014-08-19 Full Spectrum Laboratories Limited Cannabinoid formulations
GB2495118B (en) * 2011-09-29 2016-05-18 Otsuka Pharma Co Ltd A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
CN104302193A (zh) * 2012-03-16 2015-01-21 詹尼弗·赖特 基于大麻的婴儿配方食品和制备其的方法
WO2015020516A1 (en) 2013-08-05 2015-02-12 Sustain B.V. Improved pollen and/or pollen substitute comprising bee food composition
US9095563B2 (en) * 2013-09-26 2015-08-04 Ronald D. Sekura Topical treatments incorporating Cannabis sp. derived botanical drug product
CA2931039C (en) * 2013-11-20 2022-07-12 Mary Lynch Compositions and methods for treatment of ocular inflammation and pain
CN104256243A (zh) * 2014-09-04 2015-01-07 陈航 一种组合物及其制备方法、制剂与应用
CN104381774A (zh) 2014-10-28 2015-03-04 蚌埠市珠花蜂业有限责任公司 一种治疗便秘的固体沙蒿籽蜂蜜
PT3324754T (pt) 2015-07-22 2022-11-30 Phytopharma Int Ltd Composições ingeríveis por abelhas, métodos de utilização das mesmas para produzir mel e mel produzido desse modo
CA3003094A1 (en) 2015-10-31 2017-05-04 Aharon M. Eyal Honey-cannabinoid therapeutic composition
CL2015003546A1 (es) 2015-12-03 2016-07-15 Univ Catolica De Témuco Uso de extractos naturales bioestimulantes para abejas apis mellifera
CA3007393A1 (en) 2015-12-05 2017-06-08 Canabuzz-Med Veterinary composition and methods for production and use
CN105505565A (zh) * 2015-12-28 2016-04-20 贵州航天乌江机电设备有限责任公司 一种萃取富含大麻二酚的工业大麻油的方法
GR20160200212U (el) 2016-07-14 2018-03-30 Αθανασιος Χριστοφορου Ζηκιδης Μελι και σιροπι απο καναββη

Also Published As

Publication number Publication date
US11426434B2 (en) 2022-08-30
IL285972B (en) 2022-04-01
EP3324754A1 (en) 2018-05-30
CN107846936A (zh) 2018-03-27
PT3324754T (pt) 2022-11-30
PE20181011A1 (es) 2018-06-26
IL257078A (en) 2018-03-29
AU2016295728A1 (en) 2018-02-15
EP3324754B1 (en) 2022-09-07
KR20180030908A (ko) 2018-03-26
US20220378849A1 (en) 2022-12-01
US10278996B2 (en) 2019-05-07
JP2018522590A (ja) 2018-08-16
IL285972A (en) 2021-10-31
ECSP18012359A (es) 2018-10-31
AU2016295728B2 (en) 2020-07-23
CA2993023A1 (en) 2017-01-26
BR112018001310A2 (pt) 2018-09-11
WO2017013661A1 (en) 2017-01-26
CA2993023C (en) 2020-04-28
ZA201800595B (en) 2018-11-28
NZ739334A (en) 2024-02-23
CN107846936B (zh) 2021-06-01
IL257078B (en) 2021-09-30
KR102460440B1 (ko) 2022-10-28
CO2018001115A2 (es) 2018-04-19
US20180140644A1 (en) 2018-05-24
JP6976242B2 (ja) 2021-12-08
US20190231826A1 (en) 2019-08-01
CL2018000162A1 (es) 2018-04-27
ES2931903T3 (es) 2023-01-04

Similar Documents

Publication Publication Date Title
MX2018000844A (es) Composiciones ingeribles por abejas, procedimientos para el uso de las mismas para producir miel y miel producida de esta manera.
MX2021010418A (es) Composiciones que comprenden una caseína y métodos para producir las mismas.
MX2017008442A (es) Uso de picolinamidas como fungicidas.
MX388170B (es) Polimorfos de selinexor
MX2017009720A (es) Composiciones de oligosacaridos para el uso en composiciones nutricionales y metodos para producirlas.
AU2015287674B2 (en) Topical antiviral compositions and methods of using the same
MX2016009943A (es) Composiciones de nanotribologia y metodos relacionados que incluyen nanolaminas moleculares.
EP3289087A4 (en) METHOD AND COMPOSITIONS FOR PREPARING SHRINKED MAIZE PLANTS
MY193444A (en) Cell-free production of ribonucleic acid
MX2019005855A (es) Formulaciones que se pueden pulverizar.
EP3294931A4 (en) Electrodeposited lead composition, methods of production, and uses
MX2020002123A (es) Sales de ribociclib y formas en estado sólido de las mismas.
MX2020006596A (es) Hidroxiisoxazolinas y derivados de estos.
MX2017009682A (es) Composiciones de caldo y su uso como prebioticos.
MX376782B (es) Métodos de administración de composiciones de amantadina.
MX2016010447A (es) Composiciones y metodos para tratar diabetes y enfermedades hepáticas.
IN2014MU00455A (es)
MX2018000515A (es) Compuestos fluorados de cbd, composiciones y usos de los mismos.
MX2016002314A (es) Composiciones comestibles masticables.
EP3148517A4 (en) Compositions and methods to promote bone formation
MX2017000829A (es) Composiciones de azucares para la formacion de comprimidos mediante compresion directa.
IN2014CH00151A (es)
MX2015016603A (es) Composiciones de corticosteroides.
MX2016008821A (es) Composiciones lacteas fermentadas coladas y aireadas.
PH12017501869A1 (en) (s)-2'-vinyl-abscisic acid derivatives